A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial‐onset seizures in daily clinical practice: The VITOBA study

OBJECTIVE: Evidence for the efficacy and safety of adjunctive lacosamide in the treatment of partial‐onset seizures (POS) was gained during placebo‐controlled clinical trials in patients with treatment‐resistant seizures who were taking one to three concomitant antiepileptic drugs (AEDs). The VITOBA...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Epilepsia
المؤلفون الرئيسيون: Runge, Uwe, Arnold, Stephan, Brandt, Christian, Reinhardt, Fritjof, Kühn, Frank, Isensee, Kathleen, Ramirez, Francisco, Dedeken, Peter, Lauterbach, Thomas, Noack‐Rink, Matthias, Mayer, Thomas
التنسيق: Artigo
اللغة:Inglês
منشور في: John Wiley and Sons Inc. 2015
الموضوعات:
Full‐length Original Research
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC4737283/
https://ncbi.nlm.nih.gov/pubmed/26526971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/epi.13224
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة